Progression of renal disease: current concepts and therapeutic approaches

Area of Science:

• Nephrology
• Pathophysiology
• Pharmacology

Background:

• Progressive renal disease pathogenesis involves systemic hypertension and intrarenal hemodynamic or metabolic factors, including inflammation.
• Current knowledge largely stems from rodent studies, but other species show more varied pathology after renal mass reduction.
• Extrapolating animal study results to human disease progression is challenging and potentially unsafe.

Purpose of the Study:

• To highlight the limitations of current animal models in understanding human progressive renal disease.
• To discuss the unknown mechanisms of renal disease progression in humans.
• To review current therapeutic recommendations for chronic renal disease management.

Main Methods:

• Review of existing literature on renal disease pathogenesis and animal models.
• Analysis of factors complicating clinical trials in renal disease progression.
• Examination of current therapeutic strategies and their intrarenal effects.

Main Results:

• Animal models, particularly rodents, may not fully represent the complexity of human renal disease progression.
• Human mechanisms of renal disease progression remain largely undetermined.
• Therapeutic strategies include managing phosphorus, lipids, and blood pressure, with certain agents like ACE inhibitors and calcium antagonists showing specific intrarenal advantages.

Conclusions:

• The mechanisms of human progressive renal disease are not well understood.
• Effective management of chronic renal disease requires addressing multiple factors, including systemic hypertension.
• Specific antihypertensive agents may offer additional benefits for intrarenal health.